Global Competition Review recognized Cooley and its partners in the GCR 100, its annual listing and analysis of the world’s top competition and antitrust law practices.

The firm’s antitrust and competition team was Highly Recommended in Washington, DC, for its representation of Horizon Therapeutics in its $27.8 billion acquisition by Amgen, in which the firm successfully defended Horizon against the Federal Trade Commission. Cooley was also highlighted for representing One Medical in its $3.9 billion sale to Amazon and Arena Pharmaceuticals in its $6.7 billion sale to Pfizer. In litigation, the firm was noted for representing the National Association of Realtors (NAR) in multiple class actions and defending the Pac-12 Conference against allegations of conspiring to prevent student-athletes from receiving compensation for their name, image and likeness.

Read GCR’s coverage in Washington, DC

In London, Cooley’s antitrust and competition team was Recommended for its representation of Trelleborg in its sale of Trelleborg Wheel Systems to The Yokohama Rubber Company. The London team also assisted Horizon Therapeutics in its successful defense against the FTC’s challenge to its $27.8 billion acquisition by Amgen. The firm was further noted for its practice expansion through the lateral hiring of Mark Simpson.

Read GCR’s coverage in London

Additionally, the firm’s antitrust and competition practice was Recommended in Brussels for its representation of Condor as a third-party complainant in the Lufthansa/ITA and IAG/Air Europa airline mergers, where the European Commission (EC) cleared the Lufthansa/ITA deal with slot divestment remedies, while the IAG/Air Europa merger collapsed. Cooley’s cartel practice was also recognized for representing Clarios in an EC investigation, which led to the agency issuing a statement of objections to several companies in November 2023.

Read GCR’s coverage in Brussels

This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as "Cooley"). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction, and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. When advising companies, our attorney-client relationship is with the company, not with any individual. This content may have been generated with the assistance of artificial intelligence (Al) in accordance with our Al Principles, may be considered Attorney Advertising and is subject to our legal notices.